29 results
8-K
EX-10.1
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
Act of 2009, and the Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Affordability Reconciliation Act
424B3
zets121b8ubjvf3o
4 Apr 23
Prospectus supplement
4:57pm
POS AM
0clphy xbi3ar4g14zy
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
8-K
EX-10.1
axnfxb
16 May 22
Entry into a Material Definitive Agreement
9:49pm
424B4
ybg6y1ip5otv0e
17 Jun 21
Prospectus supplement with pricing info
4:31pm
8-K
EX-1.1
6xkfz6xy7v763lp39o
16 Jun 21
Inhibikase Therapeutics Prices Follow-On Public Offering of Common Stock
9:20am
DRS
EX-1.1
mnwfx19
2 Jun 21
Draft registration statement
12:00am
DRS
0xxjkebu90fb
2 Jun 21
Draft registration statement
12:00am
10-K
8ivohj8
31 Mar 21
Annual report
2:14pm